Annals of the Rheumatic Diseases, 0003-4967

Journal

1 - 10 out of 154Page size: 10

Publications

  1. 2020
  2. E-pub ahead of print

    Hydroxychloroquine shortages among patients with systemic lupus erythematosus during the COVID-19 pandemic: experience of the Systemic Lupus International Collaborating Clinics

    Caroline Gordon, 25 Jun 2020, In : Annals of the Rheumatic Diseases.

    Research output: Contribution to journal › Letter

  3. Accepted/In press

    Rituximab as therapy to induce remission after relapse in ANCA-associated vasculitis

    Lorraine Harper, Apr 2020, (Accepted/In press) In : Annals of the Rheumatic Diseases.

    Research output: Contribution to journal › Article

  4. Published

    EULAR recommendations for the management of Sjögren's syndrome with topical and systemic therapies

    Benjamin Fisher & 2 others, Simon Bowman, Jan 2020, In : Annals of the Rheumatic Diseases. 79, 1, p. 3-18 16 p., 216114.

    Research output: Contribution to journal › Article

  5. 2019
  6. E-pub ahead of print

    Open-label randomised pragmatic trial (CONTACT) comparing naproxen and low-dose colchicine for the treatment of gout flares in primary care

    Raymond Oppong, Sue Jowett, 30 Oct 2019, In : Annals of the Rheumatic Diseases. p. 1-9 9 p.

    Research output: Contribution to journal › Article

  7. Published

    Urine metabolic profile in rheumatoid arthritis development

    Stephen Young, 27 Jun 2019, In : Annals of the Rheumatic Diseases. 78, Suppl 2, p. 2129-2130 2 p.

    Research output: Contribution to journal › Abstract

  8. Published

    2019 update of the EULAR recommendations for the management of systemic lupus erythematosus

    Caroline Gordon, 29 Mar 2019, In : Annals of the Rheumatic Diseases. 78, 6, p. 736-745 10 p.

    Research output: Contribution to journal › Review article

  9. Published

    Current challenges in the development of new treatments for lupus

    Caroline Gordon, 12 Jan 2019, In : Annals of the Rheumatic Diseases. 78, 6, p. 729-735 7 p.

    Research output: Contribution to journal › Article

  10. Published

    Phosphatidylinositol 3-kinase delta pathway: a novel therapeutic target for Sjögren's syndrome

    Saba Nayar, Joana Campos, David Gardner, Christopher Buckley, Simon Bowman, Benjamin Fisher & Francesca Barone, 10 Jan 2019, In : Annals of the Rheumatic Diseases. 78, 2, p. 249-260 12 p.

    Research output: Contribution to journal › Article

  11. E-pub ahead of print

    Mycophenolate mofetil versus cyclophosphamide for remission induction in ANCA associated vasculitis: a randomised, non-inferiority trial

    Lorraine Harper, 5 Jan 2019, In : Annals of the Rheumatic Diseases.

    Research output: Contribution to journal › Article

  12. 2018
  13. Published

    Low aspirin use and high prevalence of preeclampsia risk factors among pregnant women in a multinational SLE inception cohort

    Caroline Gordon, 20 Dec 2018, In : Annals of the Rheumatic Diseases.

    Research output: Contribution to journal › Letter

Previous 1 2 3 4 5 6 7 8 ...16 Next